| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 02/26/2004 | WO2002038796A3 Methods for determining protease cleavage site motifs |
| 02/26/2004 | US20040039160 Comprises therapeutic agent, oligopeptide having an isoleucine residue, stabilizing group, and, optionally, a linker group; prodrug is cleavable by an enzyme associated with target cell; antitumor agents |
| 02/26/2004 | US20040038907 For healing wounds/tissue repair |
| 02/26/2004 | US20040038905 Anticancer agents |
| 02/26/2004 | US20040038897 Stimulates a sexual and/or erectile response in a mammal |
| 02/26/2004 | US20040038872 Inhibitors of hepatitis C virus |
| 02/26/2004 | US20040038331 Solid phase synthesis of biomolecule conjugates |
| 02/26/2004 | US20040037775 Treating and preventing autoimmune diseases. The compositions and methods utilize peptides that are cell-specific. The peptides are conjugated to drugs. The peptide-drug conjugate can be internalized by the targeted cells thereby allowing for |
| 02/25/2004 | EP1391518A1 Process for producing peptide |
| 02/25/2004 | EP1391461A1 Bicyclic lactam inhibitors of interleukin-1-beta converting enzyme |
| 02/25/2004 | EP1390405A2 Preparation of cholecystokinin agonists and antagonists and their therapeutic and diagnostic use |
| 02/25/2004 | EP1390393A2 Pentapeptide compounds and uses related thereto |
| 02/25/2004 | EP1390055A2 Tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 02/25/2004 | EP1390018A1 A pharmaceutical tablet having a high api content |
| 02/25/2004 | EP1390011A2 Control of compactability through crystallization |
| 02/25/2004 | EP1220868B1 Extracorporeal endotoxin removal method |
| 02/25/2004 | CN1139599C Process for prepaing pharmacologically acceptable salts of N-(1-(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl amino acids |
| 02/24/2004 | US6696481 Immediate-release tablets; treatment of arterial hypertension and heart failure |
| 02/24/2004 | US6696438 Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| 02/24/2004 | US6696418 Somatostatin antagonists and agonists that act at the SST subtype 2 receptor |
| 02/24/2004 | US6696412 Purification of daptomycin by binding to ion exchange resins in the presence of buffers and chaotropic agents, then eluting and recovering; peptide antibiotics |
| 02/24/2004 | US6696303 Inhibition of amyloid protein bnding to neuronal receptor; obtain cell, incubate with modulator, monitor amyloid protein activity |
| 02/19/2004 | WO2004015392A2 Improved method to identify targeting molecules |
| 02/19/2004 | WO2004014944A1 Microbial-origin polyamino acids or derivatives thereof |
| 02/19/2004 | WO2004014943A2 Biphalin derivates and their analgesic applications |
| 02/19/2004 | WO2004014882A2 Proteasome inhibitors : peptide derivatives having c-terminal heteroaryl groups |
| 02/19/2004 | WO2004014415A1 Growth hormone releasing peptides |
| 02/19/2004 | WO2004014311A2 Nogo receptor antagonists |
| 02/19/2004 | WO2004005326A3 Tubulysin conjugates |
| 02/19/2004 | WO2003065987A3 Granzyme b inhibitors |
| 02/19/2004 | WO2003045974A3 Methods and compositions for derepression of iap-inhibited caspase |
| 02/19/2004 | WO2002094778A3 Peptide conjugates and fluorescence detection methods for intracellular caspase assay |
| 02/19/2004 | WO2002069884A3 A sunburn treatment and sunburn prevention method |
| 02/19/2004 | US20040034202 Ketone spirocyclopropaneindene compounds; antineoplastic agents to inhibit tumor cell growth in vitro or in vivo; particularly effective against solid tumors and multi-drug resistant tumors |
| 02/19/2004 | US20040033958 Such as (N-((R,S)-2-(2-(N-methyl)pyrrolidinyl)ethyl)glycyl)-(N-(4 -methoxyphenethyl)glycyl)-N-(3-methylbutyl)glycinamide; for treatment of pain |
| 02/19/2004 | US20040033235 Inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells. |
| 02/19/2004 | CA2495121A1 Nogo receptor antagonists |
| 02/19/2004 | CA2494551A1 Improved method to identify targeting molecules |
| 02/18/2004 | EP1389624A1 Phosphorous-containing cysteine and serine protease inhibitors |
| 02/18/2004 | EP1389200A1 Substituted n-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors |
| 02/18/2004 | EP1089755B1 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms |
| 02/18/2004 | EP1076663B1 Functionalized alkyl and alkenyl side chain derivatives of glycinamides as farnesyl transferase inhibitors |
| 02/18/2004 | EP1000086B1 Alatrofloxacin parenteral compositions |
| 02/18/2004 | EP0946166B1 Use of matrix metalloproteinase inhibitors for promoting wound healing |
| 02/18/2004 | CN1138766C Processes for preparation of oxo-oxazoline or alloamino acid derivatives |
| 02/18/2004 | CN1138472C Dipeptide apoptosis inhibitors and use thereof |
| 02/17/2004 | US6693214 Intermediate for sweetener with high sweetness and process for producing the same |
| 02/17/2004 | US6693199 Deprotecting carbamate group and amidating in presence of such as hydroxybenzotriazole hydrate promoter |
| 02/17/2004 | US6693168 Chiral cyanoamines and methods of preparation |
| 02/17/2004 | US6693167 Peptide-based gemini compounds |
| 02/17/2004 | US6693165 Cyclic peptides as potent and selective melanocortin-4 receptor antagonists |
| 02/17/2004 | US6693120 Spray drying of thrombin inhibitors |
| 02/17/2004 | US6693099 Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
| 02/17/2004 | US6693096 Treatment of inflammation-associated disorders using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors |
| 02/17/2004 | US6693072 Short, synthetic peptides; antiinflammatories for neutrophil associated diseases |
| 02/17/2004 | CA2280279C Indole, indazole and benzimidazole derivatives as antithrombotic agents |
| 02/12/2004 | WO2004013098A1 Novel gamma-lactams as beta-secretase inhibitors |
| 02/12/2004 | WO2004012816A1 Antibacterial ester macrocycles |
| 02/12/2004 | WO2004012756A1 New cytotoxic cyclopeptide and its use for the treatment of cancer |
| 02/12/2004 | WO2004012574A2 Negative selections assays, and compositions thereof |
| 02/12/2004 | WO2003062261A3 Dmt-tic di- and tri-peptidic derivatives and related compositions and methods of use |
| 02/12/2004 | WO2003037916A3 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 02/12/2004 | WO2003014698A3 Biological assay detection method |
| 02/12/2004 | WO2003008438A3 Cosmetic or dermatological use of peptides for promoting adhesion between skin cells |
| 02/12/2004 | WO2002100344A3 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 02/12/2004 | US20040030105 Improved methods for synthesis of phosphinothiol reagents and novel protected reagents for use in peptide ligation |
| 02/12/2004 | US20040029868 Multiple sclerosis; atherosclerosis; inflamamtory bowel diseases; asthma |
| 02/12/2004 | US20040029814 Cathepins inhibitor; antiinflammatory agents; antiarthritic agents |
| 02/12/2004 | US20040029813 Cardiovascular disorders; hypotensive agents; angiotensin converting enzyme inhibitor |
| 02/12/2004 | US20040029812 Skin disorders; aging resistance |
| 02/12/2004 | US20040029811 N-alkylglycine trimeres capable of protecting neurons against excitotoxic aggressions and compositions containing such trimeres |
| 02/12/2004 | US20040029808 Binding antibody to estradiol; test device |
| 02/12/2004 | US20040029778 Prostate specific antigen; immobilization; antiproliferative agents; drug delivery |
| 02/12/2004 | DE10234422A1 Antibakterielle Ester-Makrozyklen Antibacterial ester macrocycles |
| 02/12/2004 | CA2495479A1 Antibacterial ester macrocycles |
| 02/11/2004 | EP1388537A1 Arginine derivatives |
| 02/11/2004 | EP1157998B1 Heterocyclic compounds, intermediates thereof and elastase inhibitors |
| 02/11/2004 | EP1086113B1 Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use |
| 02/11/2004 | CN1137891C Process for preparing growth hormone cinogenic agent |
| 02/10/2004 | US6689902 Reductive alkylation |
| 02/10/2004 | US6689787 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 02/10/2004 | US6689754 Heterocyclic glycyl β-alanine derivatives |
| 02/10/2004 | US6689753 Alzheimer inhibitor peptide ia beta 5 (amino acid sequence 1leu-pro-phe-phe-asp) analog |
| 02/10/2004 | US6689337 Vitronectin receptor antagonist pharmaceuticals |
| 02/10/2004 | CA2297134C A novel process for preparing intermediates or inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |
| 02/05/2004 | WO2004011652A1 Process for producing tripeptide or higher peptide |
| 02/05/2004 | WO2004011476A1 Glyconjugates comprising carbohydrate epitopes, methods for theirsynthesis, and their use for the treatment or prophylaxis of cancer |
| 02/05/2004 | WO2003097089A3 Attenuation of metapneumovirus |
| 02/05/2004 | WO2003072735A3 Use of peptide-drug conjugation to reduce inter-subject variability of drug serum levels |
| 02/05/2004 | WO2003072034A3 Cyclic peptides and analogs useful to treat allergies |
| 02/05/2004 | WO2003064455A3 Macrocyclic peptides active against the hepatitis c virus |
| 02/05/2004 | WO2003046137A3 Hiv envelope v3-ccr5 binding site immunogen |
| 02/05/2004 | WO2002100886A8 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 02/05/2004 | WO2002100883A3 Libraries of conformationally constrained peptides, chiral azacrowns, and peptidomimetics and methods of making the same |
| 02/05/2004 | US20040024180 By heating suitable dipeptides in organic solvent whilst removing water by distillation; use as chiral catalysts, e.g. for the production of chiral cyanohydrines |
| 02/05/2004 | US20040023888 Retinol derivatives, the method of preparations and the uses thereof |
| 02/05/2004 | CA2802205A1 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 02/04/2004 | EP1386166A2 Anti-epileptogenic agents |
| 02/04/2004 | EP1385882A2 Peptides and related molecules that bind to tall-1 |
| 02/04/2004 | EP1385870A2 Peptides as ns3-serine protease inhibitors of hepatitis c virus |